OpenAI’s rebrand is meant to make the company appear ‘more human’
OpenAI has rebranded its look with tweaks to its signature blossom logo and a new typeface called OpenAI Sans, hoping to have ...
ReadWrite23h
OpenAI unveils fresh rebrand with new logo and typeface
OpenAI reveals a sleek rebrand featuring a refined logo, custom typeface, and cohesive design, blending human creativity with ...
D.C. biotech Vanda Pharmaceuticals acquires AnaptysBio’s drug for rare skin disorder
D.C.’s Vanda Pharmaceuticals Inc. has locked in a deal with a West Coast biotech to commercialize a drug for a rare skin ...
Vanda stock holds Buy rating, $18 target from H.C. Wainwright
H.C. Wainwright maintained a Buy rating on Vanda Pharmaceuticals (NASDAQ:VNDA) with a price target of $18.00, representing significant upside potential from the current price of $4.31. According to ...
AnaptysBio initiated with an Outperform at Wolfe Research
Wolfe Research analyst Andy Chen initiated coverage of AnaptysBio (ANAB) with an Outperform rating and $25 price target The stock’s current ...
Howard Hughes Medical Institute2d
Through science and education, we can change the world.
HHMI's Janelia Research Campus in Ashburn, Virginia, brings together teams of scientists to unlock the fundamentals of biology. The Center plays a key role in HHMI's efforts to intentionally integrate ...
Vanda Pharmaceuticals and Anaptys Announce Exclusive Global License Agreement for Vanda to Develop and Commercialize Imsidolimab, an IL-36R Antagonist
Imsidolimab has successfully completed two global Phase 3 studies in Generalized Pustular PsoriasisVanda expects to immediately begin preparing ...